Form 8-K Alexza Pharmaceuticals For: Aug 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Roth Capital Downgrades Alexza Pharma (ALXA) to Neutral
August 8, 2014 6:44 AM EDTRoth Capital downgraded Alexza Pharma (NASDAQ: ALXA) from Buy to Neutral with a price target of $5.50 (from $10.00).
For an analyst ratings summary and ratings history on Alexza Pharma click here. For more ratings news on Alexza Pharma click here.
Shares of Alexza Pharma closed at $4.86 yesterday.
... MoreAlexza Pharmaceuticals, Inc. (ALXA) Posts Q2 Loss of 34c/Share
August 7, 2014 4:39 PM EDTAlexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q2 EPS of ($0.34), $0.33 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $2.24 million.
For earnings history and earnings-related data on Alexza Pharmaceuticals, Inc. (ALXA) click here.
... More